Modular Medical (MODD) Competitors $0.86 -0.02 (-2.05%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MODD vs. SGHT, OBIO, INFU, AVR, ZJYL, KRMD, MGRM, FONR, NSPR, and SRTSShould you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Sight Sciences (SGHT), Orchestra BioMed (OBIO), InfuSystem (INFU), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), FONAR (FONR), InspireMD (NSPR), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. Modular Medical vs. Sight Sciences Orchestra BioMed InfuSystem Anteris Technologies Global Jin Medical International KORU Medical Systems Monogram Orthopaedics FONAR InspireMD Sensus Healthcare Sight Sciences (NASDAQ:SGHT) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Does the media prefer SGHT or MODD? In the previous week, Sight Sciences had 4 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Sight Sciences and 1 mentions for Modular Medical. Sight Sciences' average media sentiment score of 0.50 beat Modular Medical's score of 0.44 indicating that Sight Sciences is being referred to more favorably in the media. Company Overall Sentiment Sight Sciences Neutral Modular Medical Neutral Which has more volatility and risk, SGHT or MODD? Sight Sciences has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Does the MarketBeat Community favor SGHT or MODD? Sight Sciences received 18 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 29.85% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformSight SciencesOutperform Votes2029.85% Underperform Votes4770.15% Modular MedicalOutperform Votes2100.00% Underperform VotesNo Votes Which has better valuation & earnings, SGHT or MODD? Modular Medical has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSight Sciences$79.87M1.68-$55.55M-$1.03-2.53Modular MedicalN/AN/A-$17.47M-$0.53-1.63 Do institutionals and insiders believe in SGHT or MODD? 55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by insiders. Comparatively, 20.5% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate SGHT or MODD? Sight Sciences currently has a consensus price target of $3.83, indicating a potential upside of 46.87%. Given Sight Sciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Sight Sciences is more favorable than Modular Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Modular Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SGHT or MODD more profitable? Modular Medical has a net margin of 0.00% compared to Sight Sciences' net margin of -63.30%. Sight Sciences' return on equity of -47.28% beat Modular Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sight Sciences-63.30% -47.28% -32.72% Modular Medical N/A -197.97%-162.31% SummarySight Sciences beats Modular Medical on 12 of the 17 factors compared between the two stocks. Remove Ads Get Modular Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MODD vs. The Competition Export to ExcelMetricModular MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.05M$4.08B$5.28B$7.36BDividend YieldN/A39.51%5.11%4.32%P/E Ratio-1.6327.7721.6317.68Price / SalesN/A49.01371.0892.88Price / CashN/A51.0838.1534.64Price / Book3.455.836.373.94Net Income-$17.47M$67.64M$3.20B$247.45M7 Day Performance-6.30%-0.76%1.79%0.48%1 Month Performance-4.12%-3.81%-9.41%-7.08%1 Year Performance-44.39%14.16%9.61%-0.35% Modular Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MODDModular Medical0.9623 of 5 stars$0.86-2.0%N/A-43.9%$35.05MN/A-1.6320Short Interest ↑Positive NewsSGHTSight Sciences3.414 of 5 stars$2.21-3.9%$3.83+73.5%-54.4%$113.45M$79.87M-2.17210OBIOOrchestra BioMed1.6712 of 5 stars$2.83+2.5%$15.00+430.0%-41.7%$107.58M$2.64M-1.764Positive NewsGap DownINFUInfuSystem1.4268 of 5 stars$5.00+1.8%$13.00+160.0%N/A$105.05M$134.86M83.35410High Trading VolumeAVRAnteris Technologies GlobalN/A$2.90-9.9%$16.50+469.0%N/A$104.47M$2.71M0.00138News CoveragePositive NewsGap UpZJYLJin Medical InternationalN/A$0.64+4.1%N/A-75.6%$100.49M$23.50M0.00245Positive NewsGap DownKRMDKORU Medical Systems2.692 of 5 stars$2.14-6.1%$4.70+119.6%+15.4%$98.35M$33.65M-8.5680MGRMMonogram Orthopaedics2.7033 of 5 stars$2.52+0.8%$5.40+114.3%+4.2%$88.93M$364,999.00-5.3628Short Interest ↑News CoverageGap DownFONRFONAR1.31 of 5 stars$13.00-2.8%N/A-27.9%$80.64M$101.57M11.30480Short Interest ↑NSPRInspireMD2.0187 of 5 stars$2.59-1.9%$4.75+83.4%+8.4%$76.90M$7.01M-3.4550Gap UpSRTSSensus Healthcare2.4797 of 5 stars$4.48+0.4%$13.00+190.2%+45.3%$73.90M$41.81M11.2040Gap Down Remove Ads Related Companies and Tools Related Companies SGHT Alternatives OBIO Alternatives INFU Alternatives AVR Alternatives ZJYL Alternatives KRMD Alternatives MGRM Alternatives FONR Alternatives NSPR Alternatives SRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MODD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Modular Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Modular Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.